Lv61
3080 积分 2023-08-23 加入
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
6天前
已完结
Reconstitution of an Anti‐HER2 Antibody Paratope by Grafting Dual CDR‐Derived Peptides onto a Small Protein Scaffold
6天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
12天前
已完结
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
19天前
已完结
Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
24天前
已完结
Current landscape of CD3 bispecific antibodies in hematologic malignancies
1个月前
已完结
Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies
1个月前
已完结
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution
1个月前
已完结
Novel antibody-drug conjugate based on DXd-ADC technology
1个月前
已完结
HHLA2 immune-regulatory roles in cancer
1个月前
已完结
皖公网安备34019202002308
